retatrutide trial status Lilly's triple agonist delivers up to 71.2 lbs of weight loss Retatrutide vs Tirzepatide: Which Peptide
Description
The approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly.
And the weight usually comes back, doctors say.
No insurance needed and no membership fees
Gallus answers your top questions.
